Antonio Nuccio - Publications

Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 14, 2026

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer

Published: January 11, 2026

Next-generation multicenter studies: using artificial intelligence to automatically process unstructured health records of patients with lung cancer across multiple institutions.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 23, 2025

Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 20, 2025

A viable human lung cancer tissue collection (LCTC) to accelerate translational research.

Journal: Cancer treatment and research communications

Published: July 21, 2025

Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: June 25, 2025

PD-L1-Overexpressing NSCLC: Overcoming All-Comer Approach and Network Effect to Weather the "Winter" of Cancer Immunotherapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 28, 2025

Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis.

Journal: EClinicalMedicine

Published: April 24, 2025

Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis.

Journal: Journal of the National Cancer Institute

Published: October 02, 2024

Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 12, 2024

Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 01, 2024

Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 21, 2024